Association Between Race, Ethnicity, and Sex With Colorectal Cancer Screening Use Among US Adults With and Without Self-Reported Depressive Disorders, Behavioral Risk Factor Surveillance System, 2022
Preventing Chronic Disease · 16.04.2026 · 23
DOI: 10.5888/pcd23.250296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Preventing Chronic Disease, online erschienen am 16.04.2026. Verfasst von Blanca Muñoz Villareal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Mass…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Depressive Disorder, Early Detection of Cancer, Ethnicity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Introduction
Colorectal cancer (CRC) is the third leading cause of cancer death in men and the fourth in women in the US. Racial, ethnic, and sex disparities persist, and people with depressive disorders may delay or skip CRC screening, contributing to later-stage diagnosis and worse outcomes. We examined the association between sex, race, ethnicity, and CRC screening by depression history.
Methods
We analyzed 2022 Behavioral Risk Factor Surveillance System data for adults aged 45 to 74 years (n = 222,601), classifying CRC screening status as up to date or not up to date/never screened. The main predictors were sex, race, and ethnicity (eg, non-Hispanic Black women) and self-reported depression. We used Poisson regression to estimate adjusted prevalence ratios (aPRs).
Results
The weighted sample represented approximately 108 million United States adults aged 45 to 74 years. People with depression were slightly more likely to be up to date with CRC screening (aPR = 1.05; 95% CI, 1.04-1.07) compared with those without depression. Asian (aPR = 0.77; 95% CI, 0.72-0.83), American Indian or Alaska Native (aPR = 0.81; 95% CI, 0.75-0.88), and Hispanic (aPR = 0.83; 95% CI, 0.80-0.86) people were less likely to be up to date compared with White people. After adjusting for confounders, we found that depression was associated with increased screening only among White women, who were 4% more likely to be up to date (aPR = 1.04; 95% CI, 1.01-1.07) than White men with depression.
Conclusion
Outreach programs should aim to increase awareness of and accessibility to CRC screening among people who are at high-risk for CRC, such as Hispanic and Asian populations. More research is needed to better understand how depression and its symptoms influence CRC screening use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts.
Förderung
- NIA NIH HHS
- NCATS NIH HHS
Zitieren
APA
Villareal, B. M., Nielsen, N., Yuan, Y., & Castañeda-Avila, M. (2026). Association Between Race, Ethnicity, and Sex With Colorectal Cancer Screening Use Among US Adults With and Without Self-Reported Depressive Disorders, Behavioral Risk Factor Surveillance System, 2022. Preventing Chronic Disease, 23. https://doi.org/10.5888/pcd23.250296
Vancouver
Villareal BM, Nielsen N, Yuan Y, Castañeda-Avila M. Association Between Race, Ethnicity, and Sex With Colorectal Cancer Screening Use Among US Adults With and Without Self-Reported Depressive Disorders, Behavioral Risk Factor Surveillance System, 2022. Preventing Chronic Disease. 2026;23. doi:10.5888/pcd23.250296
BibTeX
@article{Villareal2026,
author = {Villareal, Blanca Muñoz and Nielsen, Natalia and Yuan, Yiyang and Castañeda-Avila, Maira},
title = {Association Between Race, Ethnicity, and Sex With Colorectal Cancer Screening Use Among US Adults With and Without Self-Reported Depressive Disorders, Behavioral Risk Factor Surveillance System, 2022},
journal = {Preventing Chronic Disease},
year = {2026},
volume = {23},
doi = {10.5888/pcd23.250296}
}
EUVIMED